CRISPR Therapeutics AG: Pay

CRISPR Therapeutics AG paid its 5 named executives $22.1M in total in FY2025 (Dec). CEO Samarth Kulkarni, Ph.D was paid $7.7M of that.

Pay$100 in the stock at the end of FY20 → $34
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Samarth Kulkarni, Ph.DChairman and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Naimish Patel, M.D.Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Julianne Bruno, M.B.A.Former Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Raju Prasad, Ph.D.Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
James R. KasingerGeneral Counsel
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2023 (Dec), the median CEO pay of the 5 peers with pay on file was $12.2M. The CEO of CRISPR Therapeutics AG was paid $12.3M, 1% above the median.

  1. 1Neurocrine Biosciences
  2. 2Ionis Pharmaceuticals
  3. 3CRISPR Therapeutics AG
  4. 4BridgeBio Pharma
  5. 5Alnylam Pharmaceuticals
  6. 6Beam Therapeutics
  7. 7Allogene TherapeuticsNot disclosed
  8. 8Apellis PharmaceuticalsNot disclosed
  9. 9Arrowhead PharmaceuticalsNot disclosed
  10. 10Blueprint MedicinesNot disclosed
  11. 11Cerevel TherapeuticsNot disclosed
  12. 12Denali TherapeuticsNot disclosed
  13. 13Editas MedicineNot disclosed
  14. 14Fate TherapeuticsNot disclosed
  15. 15Intellia TherapeuticsNot disclosed
  16. 16Iovance BioTherapeuticsNot disclosed
  17. 17Mirati TherapeuticsNot disclosed
  18. 18Sarepta TherapeuticsNot disclosed
  19. 19Ultragenyx PharmaceuticsNot disclosed
  20. 20Vir BiotechnologyNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.